期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

妊娠合并肺动脉高压的处理 被引量：5

原文传递
导出
摘要 随着孕期保健的开展及产科质量的提高，孕产妇死亡率逐年下降，但由于妊娠合并心脏病患者的增多，而导致的孕产妇死亡率明显增加，尤其肺动脉高压（PAH）患者妊娠猝死的危险性更大，孕产妇死亡率与肺动脉压力的高低密切相关，重度肺动脉高压者死亡率高达50％以上。因此妊娠合并肺动脉高压已引起产科学者的高度重视。
作者 马玉燕
机构地区 山东大学齐鲁医院妇产科
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第11期730-732,共3页 National Medical Journal of China
关键词 重度肺动脉高压 妊娠 孕产妇死亡率 产科质量 心脏病患者 肺动脉压力 孕期保健
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献9

  • 1Martinez J, Comas C, Sala X, et al. Materal primary pulmonary arterial hypertension associated with pengnancy. Europ J Obstet Gynaeeol Reprod Biol , 1994,54 : 143-147.
  • 2Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical pratice guidelines. Chest,2004,126Suppl 1:7-10.
  • 3Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coil Cardio1,2004 ,43 :5-12.
  • 4Lieber S, Dewilde PH, Huyghens L, et al. Eisenmenger's syndrome and pregnancy. Acta Cardiol, 1985,40:421-424.
  • 5Heytens L, Alexander JP. Maternal and neonatal death associated with Eisenmenger's syndrome. Acta Anaesthesiol Belg, 1986,37 : 45-51.
  • 6Olschewski H, Simonneau G, Galie N, et al. Inhaled Iloprost for severe pulmonary hypertension. N Engl J Med, 2002,347: 322- 329.
  • 7Elliot CA, Stewart P, Webster VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J, 2005,26 : 168-173.
  • 8Avdalovic M, Sandrock C, Hoso A, et al. Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature. Treat Respir Med ,2004,3 : 29-34.
  • 9Lam GK, Stafford RE, Thorp J, et al. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol, 2001,98(5 Pt 2) :895-898.

同被引文献61

  • 1邱蔚六.临床决策需要辩证思维[J].医学与哲学（B）,2006,27(7):1-2. 被引量：12
  • 2田庄,刘永太,朱文玲,方全.伊洛前列素治疗妊娠合并特发性肺动脉高压1例报告[J].北京医学,2007,29(2):72-74. 被引量：4
  • 3Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment oS pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplantation (ISHI.T)[J]. Eur Heart J,2009,30(20):2493-2537.
  • 4Madden BP. Pulmonary hypertension and pregnancy[J]. Int J Ohstet Anesth,2009,18(2):156-164.
  • 5Rosene-Montella K, Bourjeily G. Pulmonary problems in pregnaney[M]. New York : Humana Press, 2009 : 285-312.
  • 6Barker D, Williams S, Mason G, et al, Plasma brain natriuretic peptide may not be useful to assess possible cardiac symptoms during pregnancy[J]. Am J Obstet Gynecol,2006,193(6) :79.
  • 7Gleicher N, Midwall J, Hochberger D, et al. Eisennmenger' s syndrome and pregnancy[J]. Obstet Gynecol, 1979,34 (10) : 721-741.
  • 8Weiss B, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systemic overview from 1978 through 1996[J]. J Am Coil Cardiol,1998,31(7):1650-1657.
  • 9Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? [J]. Eur Heart J, 2009,30 (3) :256-265.
  • 10U. S. Department of Health and Human Services Food and Drug Administration (FDA). Summary of Proposed Rule on Pregnancy and Lactation Labeling. The Proposed RuleEEB/ OL]. ( 2008-05-29 ) E 2011-05-12 ]. http: //{rwebgate. access. gpo. gov/cgi-bin/getdoc, cgi? dbname = 2008_ register&docid = fr29my08-33.

引证文献5

二级引证文献24

中华医学杂志
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部